2018 International Congress

Saturday, October 6, 2018

1:45pm-3:15pm

Is early onset ataxia phenotypically discernible from developmental disorders with impaired coordination?

T. Lawerman, R. Brandsma, N. Maurits, O. Martinez-Manzanera, R. Lunsing, R. Brouwer, H. Kremer, D. Sival (Groningen, Netherlands)

Pediatric Movement Disorders  ·  Hall 3FG

1:45pm-3:15pm

Is lowering stimulation frequency a feasible option to improve speech in Parkinson’s disease patients undergoing subthalamic deep brain stimulation?

M. Fabbri, M. Zibetti, G. Ferrero, A. Accornero, I. Guimaraes, M. Rizzone, A. Romagnolo, J. Ferreira, L. Lopiano (Lisbon, Portugal)

Surgical Therapy: Parkinson's Disease  ·  Hall 3FG

1:45pm-3:15pm

Is there a relationship between depression/anxiety and physical inactivity in Parkinson Disease?

B. Aktar, B. Balci, B. Donmez Colakoglu (Izmir, Turkey)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment  ·  Hall 3FG

1:45pm-3:15pm

It takes two to tango but following may be more beneficial for rehabilitating people with mild-moderate Parkinson’s

M. Hackney, A. Hart, C. Kim (Atlanta, GA, USA)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment  ·  Hall 3FG

1:45pm-3:15pm

Juvenile parkinsonism associated with a novel HSD17B10 mutation in a patient with HSD10 disease

M. Rosário, O. Moldovan, S. Reimão, I. Chendo, J. Crawford, M. Rosa, L. Guedes (Lisbon, Portugal)

Rare Genetic and Metabolic Diseases  ·  Hall 3FG

1:45pm-3:15pm

Knowledge of Parkinson’s Disease in Urban Population of Kyrgyz Republic

C. Shambetova, A. Arykova, I. Nisheglotova, B. Abdildaev, SY. Lim, AH. Tan (Bishkek, Kyrgyzstan)

Education in Movement Disorders  ·  Hall 3FG

1:45pm-3:15pm

Kratom withdrawal induced orobuccal dyskinesia

K. Methawasin (Nakhon Nayok, Thailand)

Drug-Induced Movement Disorders  ·  Hall 3FG

1:45pm-3:15pm

L-Dopa responsiveness in early Parkinson’s disease: Results from the United Kingdom Tracking Parkinson’s study

N. Malek, S. Kanavou, M. Lawton, K. Grosset, V. Pitz, N. Bajaj, R. Barker, D. Burn, T. Foltynie, J. Hardy, N. Wood, N. Williams, H. Morris, Y. Ben-Shlomo, D. Grosset (Ipswich, United Kingdom)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment  ·  Hall 3FG

1:45pm-3:15pm

Level of serum Mortalin in Parkinson’s disease correlating with -Synuclein: Assessment of protein marker for early detection

S. Dey, A. Singh, T. Bajaj, A.B. Dey (New Delhi, India)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment  ·  Hall 3FG

1:45pm-3:15pm

Levodopa Effect on Dual-Tasking in Freezing of Gait in Parkinson’s Disease

E. Bayram, J. Longhurst, S. Banks, Z. Mari, B. Bluett (Las Vegas, NV, USA)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment  ·  Hall 3FG